Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Thyroid cancer is the most common endocrine cancer, and its prevalence has been
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …

Background Because beneficial response and progression‐free survival (PFS) were
achieved by well‐designed clinical trials with tyrosine kinase inhibitors (TKIs) in patients with …

Due to a global increase in the incidence of thyroid cancer, numerous novel mouse models
were established to reveal thyroid cancer pathogenesis and test promising therapeutic …

Background Because beneficial response and progression‐free survival (PFS) were
achieved by well‐designed clinical trials with tyrosine kinase inhibitors (TKIs) in patients with …

Simple Summary Molecular imaging utilizes radionuclides or artificially modified molecules
to image particular targets or pathways which are important in the pathogenesis of a certain …

The management for totally thyroidectomized differentiated thyroid cancer (TT-DTC) patients
with unexplained hyperthyroglobulinemia remains indeterminate because of evidence …

Background We aimed to develop a machine-learning model for predicting treatment
response to radioiodine (131I) therapy and thyrotropin (TSH) suppression therapy in …

Although serum thyroglobulin (Tg) is a reliable differentiated thyroid carcinoma (DTC)
prognostic marker, its cutoff values can be affected by TSH stimulation status. Serum Tg …

Purpose: We aimed to explore the efficacy and safety of iodine-131 (131I) therapy in
children and adolescents with differentiated thyroid carcinoma (DTC), and to analyze the …